Duchenne muscular dystrophy: Current state and therapeutic perspectives

被引：0
|
作者：
Le Guen, Y. T. [1 ]
Le Gall, T. [1 ]
Laurent, V [1 ]
D'Arbonneau, F. [1 ]
Braun, S. [2 ]
Montier, T. [1 ,3 ]
机构：
[1] Univ Bretagne Occidentale, INSERM, Genet Genom Fonct & Biotechnol, EFS,UMR 1078, 22 Rue Camille Desmoulins,CS 93837, F-29238 Brest 3, France
[2] AFM Telethon, 1 Rue Int,BP59, F-91002 Evry, France
[3] CHRU Brest, Serv Genet Med & Biol Reprod, Ctr Reference Malad Rares Malad Neuromusculaires, F-29200 Brest, France
来源：
BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE | 2021年 / 205卷 / 05期
关键词：
Muscular Dystrophy; Duchenne; Therapeutics; Gene Therapy; GENE-THERAPY; FEMALE CARRIERS; MUSCLE; GLUCOCORTICOIDS; CHILDREN; VECTORS; IMPACT;
D O I：
10.1016/j.banm.2020.10.019
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Duchenne muscular dystrophy is one of the most frequent muscular dystrophies, with 250,000 affected people worldwide. It results from mutations occurring in the dystrophin gene, the largest known in the human genome. Despite current therapies allow for a better clinical prognosis, the life span and the quality of life of patients still remain clearly lower than those in the general population. New therapeutic approaches are currently investigated, giving new perspectives and hopes for the care of this severe disease. (C) 2021 l'Academie nationale de medecine. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：509 / 518
页数：10
相关论文
共 50 条
  • [1] Discussion about the presentation: "Duchenne muscular dystrophy: current state and therapeutic perspectives''
    Montier, T.
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2021, 205 (06): : 632 - 633
  • [2] Duchenne and Becker muscular dystrophy in adolescents: current perspectives
    Andrews, Jennifer G.
    Wahl, Richard A.
    [J]. ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 2018, 9 : 53 - 63
  • [3] DUCHENNE MUSCULAR DYSTROPHY: CURRENT ASPECTS AND PERSPECTIVES ON TREATMENT
    Lopez-Hernandez, L. B.
    Vazquez-Cardenas, N. A.
    Luna-Padron, E.
    [J]. REVISTA DE NEUROLOGIA, 2009, 49 (07) : 369 - 375
  • [4] Duchenne muscular dystrophy: classical and new therapeutic purposes and future perspectives
    Sgobbi de Souza, Paulo Victor
    Monteiro Naylor, Fernando George
    Vieira de Rezende Pinto, Wladimir Bocca
    Bulle Oliveira, Acary Souza
    [J]. ARQUIVOS DE NEURO-PSIQUIATRIA, 2017, 75 (08) : 495 - 496
  • [5] Therapeutic strategies for Duchenne muscular dystrophy
    不详
    [J]. DRUG NEWS & PERSPECTIVES, 2005, 18 (08) : 517 - 518
  • [6] Therapeutic approaches for Duchenne muscular dystrophy
    Roberts, Thomas C.
    Wood, Matthew J. A.
    Davies, Kay E.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2023, 22 (11) : 917 - 934
  • [7] Therapeutic developments for Duchenne muscular dystrophy
    Verhaart, Ingrid E. C.
    Aartsma-Rus, Annemieke
    [J]. NATURE REVIEWS NEUROLOGY, 2019, 15 (07) : 373 - 386
  • [8] Therapeutic developments for Duchenne muscular dystrophy
    Ingrid E. C. Verhaart
    Annemieke Aartsma-Rus
    [J]. Nature Reviews Neurology, 2019, 15 : 373 - 386
  • [9] Therapeutic approaches for Duchenne muscular dystrophy
    Thomas C. Roberts
    Matthew J. A. Wood
    Kay E. Davies
    [J]. Nature Reviews Drug Discovery, 2023, 22 : 917 - 934
  • [10] Parents' perspectives on coping with Duchenne muscular dystrophy
    Webb, CL
    [J]. CHILD CARE HEALTH AND DEVELOPMENT, 2005, 31 (04) : 385 - 396
12345